Datasets

To find datasets from LINCS publications, type the relevant PMID in the datasets search box below.

HMS Dataset ID Dataset Title HMS Dataset Type
20027
AZD7762 KINOMEscan
KINOMEscan
20227
Baricitinib KINOMEscan
KINOMEscan
20137
Basal profile of receptor tyrosine kinase signaling network measured by ELISA
ELISA
20096
BEZ235 KINOMEscan
KINOMEscan
20224
BGJ398 KINOMEscan
KINOMEscan
20057
BI-2536 KINOMEscan
KINOMEscan
20149
BI-2536 KINOMEscan-2
KINOMEscan
20175
BIBF-1120 KINOMEscan
KINOMEscan
20172
BIBW-2992 KINOMEscan
KINOMEscan
20327
BI-D1870 KINOMEscan
KINOMEscan
20151
BIRB-796 KINOMEscan
KINOMEscan
20146
BMS-345541 KINOMEscan
KINOMEscan
20034
BMS345541 KINOMEscan
KINOMEscan
20171
BMS-387032 KINOMEscan
KINOMEscan
20112
BMS-536924 KINOMEscan
KINOMEscan
20180
BMS-540215 KINOMEscan
KINOMEscan
20332
BMX-IN-1 KINOMEscan
KINOMEscan
20116
Bosutinib KINOMEscan
KINOMEscan
20256
Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values.
Microscopy/Imaging
20257
Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates.
Microscopy/Imaging
20258
Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 3 of 3: Calculated dose-response metrics.
Analysis
20350
Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values.
Microscopy/Imaging
20351
Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics.
Analysis
20343
Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values
Microscopy/Imaging
20344
Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics
Analysis